NAVi Joins Australia's Premier Medtech Accelerator
After a stringent due-diligence round, NAVi is proud to announce that it has been selected as one of six startups to be accepted into the very first cohort of The Actuator Accelerator Program Australia's largest medical device focused accelerator program.
The Actuator, in partnership with the Australian Government, Artesian, MTP Connect, and a range of industry partners (including Medtonic and Johnson & Johnson), provides NAVi with initial seed funding along with an advanced mentorship program designed to accelerate the commercialisation pathway. The 15 month program consists of a structured 12 month mentor led development phase, followed by an intensive 3 month ‘investor road show’. “We are incredibly excited to be launching The Actuator—Australia’s National MedTech Accelerator,” says Dr Buzz Palmer, CEO of The Actuator. “Our mission is to support our homegrown talent within their local innovation ecosystems, and build incredible successes. We are eager to see the game-changing ideas that are bubbling, emerge out of Australia.”
One of the primary focuses of the Actuator program is to get startups ‘investment ready’ and assist with easier access to funding through partners such as venture capital partners Artesian. NAVi CEO Alex Newton is excited about the opportunities that the Actuator program offers; "Our partnership with the Actuator and Artesian means that the [Artesian Venture Capital] fund will match any external funding we raise from investors that partner with us, essentially de-risking future investors at the key funding stages."